⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Nation-wide Multicenter Clinical Epidemiologic Study of Chinese Females With Advanced Breast

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Nation-wide Multicenter Clinical Epidemiologic Study of Chinese Females With Advanced Breast

Official Title: A Nation-wide Multicenter Clinical Epidemiologic Study of Chinese Females With Advanced Breast

Study ID: NCT03047889

Interventions

standard therapy

Study Description

Brief Summary: To study the epidemiological trends and characteristics for advanced breast cancer patients, to analyze these trends and report the results

Detailed Description: In this study, the investigators conducted a hospital-based retrospective clinical study, recruiting female advanced breast cancer patients from 14 tertiary hospitals at 7 classic geographic regions, to study the clinical epidemiologic characteristics of advanced breast cancer and the current standard of clinical diagnosis and treatment in order to provide references for standardized treatment therapy, and to improve the quality of life and prolong survival time. To study the epidemiological trends and characteristics for advanced BC patients, to analyze these trends and report the results. To learn about the current treatment therapy for advanced BC patients in different areas in China.To provide references for standardized treatment therapy, to improve the quality of patients' life and to prolong the survival time for the advanced BC patients.To assess the different treatment therapies for advanced BC with consideration of economic cost-effectiveness

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: FEMALE

Healthy Volunteers: No

Locations

The 307th Hospital of Military Medical Sciences, Beijing, , China

Sichuan Cancer Hospital and Institute, Chengdu, , China

The First Affliated Hospital of Chongqing Medical University, Chongqing, , China

FuZhou General Hospital of National Miltary Command, Fuzhou, , China

Sun Yat-Sen University Cancer Center, Guangzhou, , China

Harbin Medical University Cancer Hospital, Harbin, , China

Henan Cancer Hospital, Henan, , China

Hunan Cancer Hospital, Hunan, , China

Jiangsu Provinces hospital, Jiangsu, , China

Tumor Hospital of Yunnan Province, Kunming, , China

Liaoning Cancer Hospital, Zhejiang Cancer Hospital, Liaoning, , China

General Hospital of NingXia Medical University, Ningxia, , China

Fudan University Shanghai Cancer Center, Shanghai, , China

The First Hospital of China Medical University, Shenyang, , China

Tianjin Medical University Cancer Institute & Hospital, Tianjin, , China

Wuhan Union Hospital, Wuhan, , China

The First Hospital of Xi'an Jiaotong University, Xi'an, , China

Xinjiang Medical University Cancer Hospital, Xinjiang, , China

FuJian Provincial Cancer Hospital, Zhengzhou, , China

Contact Details

Name: Binghe Xu

Affiliation: Chinese Academy of Medical Sciences

Role: PRINCIPAL_INVESTIGATOR

Name: Youlin Qiao

Affiliation: Chinese Academy of Medical Sciences

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: